The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it's coming from a children's hospital.
Nationwide Children's Hospital in Columbus, Ohio, and Transformatix Technologies, Inc., in Davis, California, have partnered to create BioLinQ, a new biomedical informatics company designed to supply advanced software solutions for disease diagnosis and medical research.
"Years of development at Nationwide Children's Hospital funded in part by the National Institutes of Health have laid the foundation for very mature, high-end solutions in digital pathology, biospecimen analysis and biorepository management," says Ken Murray, founder and CEO, Transformatix Technologies, Inc. "With the growth of molecular technology and the advent of personalized medicine, BioLinQ is poised to have a significant impact upon the diagnostic and research capabilities in hospitals, academic research centers and the pharmaceutical industry."
The vision of the late Stephen J. Qualman, MD, who developed the Biopathology Center at Nationwide Children's, provided the foundation to advance the hospital's capabilities in the field of pathology, as well as biobanking and sophisticated digital analysis. Software solutions developed at Nationwide Children's answer the needs for highly defined biospecimen analysis, workflow management, long-distance collaboration and efficient management of laboratory and biorepository functions.
"We are seeing, with the implementation of our software, the optimization of the scientific review process for translational research. The solutions also provide visualization into the multiple dynamics of clinical trial data to aid in clinical study design," explains Dave Billiter, director, Informatics, The Research Institute at Nationwide Children's Hospital. "For example, we have a cancer consortium which called for patients to receive rapid review in order to qualif
|Contact: Erin Pope|
Nationwide Children's Hospital